semaglutide peptide cost Compounded GLP-1 - & Tirzepatide Compounded Semaglutide With B6 (Pyridoxine)

Licensed by MHRA, these POM medications ensure quality care and support your health journey

Semaglutide is an FDA-approved GLP-1 receptor agonist, specifically developed for chronic weight management in adults dealing with obesity or overweight conditions

Sinha A, Rahman H, Perera D

Assuming a 10% GLP-1 usage rate among overweight adults and a 20% usage rate among obese adults in the U.S., Roe (2025) estimates this could lead to a 3% reduction in total caloric demand, which amounts to 20 billion fewer calories of food consumed per day and about $1.2 billion less spent per week

Ask your provider if tirzepatide or semaglutide is an appropriate treatment for you

Amylinits role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity